These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32722626)

  • 1. Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma.
    Yura Y; Masui A; Hamada M
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma.
    Nema R; Vishwakarma S; Agarwal R; Panday RK; Kumar A
    Onco Targets Ther; 2016; 9():3269-80. PubMed ID: 27330306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis.
    Hinkovska-Galcheva V; VanWay SM; Shanley TP; Kunkel RG
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1192-205. PubMed ID: 18951299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.
    Sordillo LA; Sordillo PP; Helson L
    Anticancer Res; 2016 May; 36(5):2085-95. PubMed ID: 27127108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells.
    Castillo SS; Teegarden D
    J Nutr; 2001 Nov; 131(11):2826-30. PubMed ID: 11694603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB; Ural AU; Avcu F; Baran Y
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
    Hait NC; Maiti A
    Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.
    Gangoiti P; Granado MH; Alonso A; Goñi FM; Gómez-Muñoz A
    Transl Oncogenomics; 2008 Apr; 3():81-98. PubMed ID: 21566746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C6 ceramide motivates the anticancer sensibility induced by PKC412 in preclinical head and neck squamous cell carcinoma models.
    Zhu Y; Wang C; Zhou Y; Ma N; Zhou J
    J Cell Physiol; 2018 Dec; 233(12):9437-9446. PubMed ID: 29968910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy.
    Korbelik M; Zhang W; Separovic D
    Photochem Photobiol Sci; 2012 May; 11(5):779-84. PubMed ID: 22354109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
    Kartal M; Saydam G; Sahin F; Baran Y
    Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.
    Chalfant CE; Spiegel S
    J Cell Sci; 2005 Oct; 118(Pt 20):4605-12. PubMed ID: 16219683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of ceramide analogs as potential anticancer agents.
    Liu J; Beckman BS; Foroozesh M
    Future Med Chem; 2013 Aug; 5(12):1405-21. PubMed ID: 23919551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid metabolizing enzymes as novel therapeutic targets.
    Billich A; Baumruker T
    Subcell Biochem; 2008; 49():487-522. PubMed ID: 18751924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate.
    Nishino S; Yamashita H; Tamori M; Mashimo M; Yamagata K; Nakamura H; Murayama T
    J Cell Biochem; 2019 Apr; 120(4):5396-5408. PubMed ID: 30444039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor, sphingomyelins, and sensitization in sensory neurons.
    Nicol GD
    Sheng Li Xue Bao; 2008 Oct; 60(5):603-4. PubMed ID: 18958367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.